安迪生物科技有限公司 - 收益表 (TTM)

安迪生物科技有限公司
KR ˙ KOSDAQ
₩2,500.00 ↓ -95.00 (-3.66%)
2026-06-05
分享價格
收益表 (TTM)

安迪生物科技有限公司收益表顯示了一段時間內收入和支出的變化。收益表的數據包括銷售和收入、毛利、研發開支(R&D)、銷售、一般及行政開支(SG&A)、營業利潤、所得稅開支、財務成本、非營業收益、每股盈利(EPS)和已發行股份。

除以每股為單位的數字外,所有數字為1,000,000倍數。

2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
收入 11,840 12,566 12,321 12,397 10,632 10,648 9,608 10,505 10,472 9,721 9,824 8,799 11,136 12,299 12,673 14,567 12,897 12,513
改變 (%) 6.13 -1.95 0.61 -14.24 0.15 -9.76 9.33 -0.31 -7.17 1.06 -10.44 26.56 10.44 3.04 14.95 -11.46 -2.98
佔收入的百分比 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
銷售成本 6,831 7,079 7,618 8,012 7,520 8,086 7,527 7,802 7,254 5,833 6,201 5,631 7,130 7,877 7,615 8,992 7,749 7,671
改變 (%) 3.63 7.62 5.17 -6.13 7.52 -6.91 3.65 -7.02 -19.60 6.32 -9.20 26.62 10.48 -3.32 18.08 -13.82 -1.01
佔收入的百分比 57.69 56.33 61.83 64.63 70.74 75.94 78.34 74.27 69.27 60.00 63.12 63.99 64.02 64.04 60.09 61.73 60.09 61.31
營業毛利 5,009 5,487 4,703 4,385 3,111 2,562 2,081 2,703 3,218 3,888 3,623 3,169 4,007 4,422 5,058 5,575 5,148 4,842
改變 (%) 9.55 -14.29 -6.76 -29.06 -17.67 -18.77 29.90 19.06 20.83 -6.81 -12.55 26.45 10.37 14.38 10.22 -7.66 -5.95
佔收入的百分比 42.31 43.67 38.17 35.37 29.26 24.06 21.66 25.73 30.73 40.00 36.88 36.01 35.98 35.96 39.91 38.27 39.92 38.69
銷售、一般及行政費用 5,752 6,432 7,665 7,403 6,720 6,703 4,953 5,534 5,860 5,491 6,024 5,526 5,989 5,981 6,724 7,784 6,443 7,147
改變 (%) 11.83 19.17 -3.42 -9.22 -0.25 -26.11 11.72 5.90 -6.29 9.69 -8.26 8.38 -0.13 12.41 15.78 -17.23 10.92
佔收入的百分比 48.58 51.18 62.21 59.71 63.21 62.96 51.55 52.68 55.96 56.49 61.31 62.80 53.78 48.63 53.05 53.44 49.96 57.12
研發 550 755 633 708 1,111 1,264 1,469 1,513 1,486 1,497 1,411 1,469 1,632 1,702 1,799 1,909 1,802 1,585
改變 (%) 37.19 -16.10 11.84 56.81 13.85 16.19 3.02 -1.79 0.69 -5.70 4.05 11.16 4.26 5.73 6.10 -5.59 -12.04
佔收入的百分比 4.65 6.01 5.14 5.71 10.45 11.87 15.29 14.41 14.19 15.40 14.37 16.69 14.66 13.84 14.20 13.11 13.97 12.67
營運支出 13,395 14,543 16,214 16,427 15,615 16,347 14,325 15,294 15,244 13,510 14,301 13,250 15,254 16,044 16,602 19,136 16,398 16,875
改變 (%) 8.57 11.49 1.32 -4.94 4.69 -12.37 6.76 -0.32 -11.37 5.85 -7.35 15.12 5.18 3.48 15.26 -14.31 2.91
佔收入的百分比 113.13 115.73 131.59 132.51 146.88 153.53 149.10 145.59 145.57 138.98 145.56 150.58 136.97 130.45 131.01 131.37 127.14 134.86
營業收入 -1,555 -1,977 -3,892 -4,030 -4,984 -5,700 -4,717 -4,789 -4,772 -3,790 -4,476 -4,451 -4,117 -3,745 -3,929 -4,569 -3,501 -4,362
改變 (%) 27.14 96.92 3.54 23.66 14.37 -17.23 1.52 -0.35 -20.60 18.12 -0.57 -7.49 -9.04 4.92 16.28 -23.38 24.60
佔收入的百分比 -13.13 -15.73 -31.59 -32.51 -46.88 -53.53 -49.10 -45.59 -45.57 -38.98 -45.56 -50.58 -36.97 -30.45 -31.01 -31.37 -27.14 -34.86
利息花費 -130 -131 -108 -98 -125 -183 -295 -381 -426 -413 -477 -540 -682 -837 -862 -1,335 -1,816 -2,277
改變 (%) 0.65 -17.81 -9.42 27.77 46.42 61.53 29.32 11.82 -3.17 15.63 13.18 26.22 22.77 2.95 54.87 36.02 25.42
佔收入的百分比 -1.10 -1.04 -0.87 -0.79 -1.17 -1.71 -3.07 -3.63 -4.07 -4.25 -4.86 -6.14 -6.12 -6.81 -6.80 -9.16 -14.08 -18.20
淨利 -2,664 -2,917 -2,542 -2,005 2,696 3,221 4,145 3,462 -2,863 -6,885 -8,350 -8,482 -7,952 -4,075 -7,290 -11,016 -3,304 -8,331
改變 (%) 9.49 -12.86 -21.14 -234.48 19.44 28.70 -16.46 -182.70 140.46 21.28 1.57 -6.25 -48.76 78.91 51.11 -70.01 152.13
佔收入的百分比 -22.50 -23.22 -20.63 -16.17 25.36 30.25 43.14 32.96 -27.34 -70.83 -85.00 -96.39 -71.41 -33.13 -57.53 -75.63 -25.62 -66.58

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista